Management of the axilla post‐neoadjuvant chemotherapy in node positive breast cancer: Can the combination of axillary ultrasound and tumor biomarkers improve patient selection for sentinel node biopsy?
Abstract
The Breast JournalVolume 27, Issue 4 p. 394-396 COMMENTARY Management of the axilla post-neoadjuvant chemotherapy in node positive breast cancer: Can the combination of axillary ultrasound and tumor biomarkers improve patient selection for sentinel node biopsy? Kate Dinneen MB BCh BAO, MD, Corresponding Author Kate Dinneen MB BCh BAO, MD katedinneen4@gmail.com orcid.org/0000-0002-1613-5503 Department of Histopathology, St. Vincent's University...
Paper Details
Title
Management of the axilla post‐neoadjuvant chemotherapy in node positive breast cancer: Can the combination of axillary ultrasound and tumor biomarkers improve patient selection for sentinel node biopsy?
Published Date
Feb 2, 2021
Journal
Volume
27
Issue
4
Pages
394 - 396
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History